StockData
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. (MRKR) stock

MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/30
$0.85+0.02 (+1.98%)

Close on Nov 18, 2026Market cap $14.23MP/E –Yield –

Marker Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Marker Therapeutics's price to sales ratio was 4.8× on Jul 31, 2026, against 2.8× a year earlier. Over the last 4 years it ranged from 1.7× to 407.3×, with a median of 6.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20264.8×−0.5
2025Dec 31, 20255.3×+0.2
2024Dec 31, 20245.1×−10.9
2023Dec 29, 202316.1×−243.5
2021Apr 30, 2021259.6×−147.7
2020Mar 31, 2020407.3×+253.8
2018Apr 30, 2018153.4×–

More Marker Therapeutics figures

See a number that looks wrong?